Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111821 (US8623906, XW2-038H | US9174969, JHE-02-023) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111823 (BDBM111857 | US8623906, JHE-02-001 | US8623906, JH...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111823 (BDBM111857 | US8623906, JHE-02-001 | US8623906, JH...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111822 (US8623906, XW2-125B | US9174969, XW2-125B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM189410 (US9174969, CDL 4340-0580) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111824 (US8623906, JHE-02-119 | US9174969, JHE-02-119) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM189411 (US9174969, NAT6-297775) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111832 (US8623906, JHE-01-129B | US9174969, JHE-01-129B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM189409 (US9174969, JHE-01-129A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111873 (US8623906, JHE-02-020B | US9174969, JHE-02-020B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111828 (US8623906, JHE-02-065B | US9174969, JHE-02-065B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111844 (US8623906, XW2-057 | US9174969, XW2-057) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111829 (US8623906, JHE-02-068B | US9174969, JHE-02-068B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111854 (US8623906, JHE-02-017C | US9174969, JHE-02-017C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111865 (US8623906, JHE-02-019A | US9174969, JHE-02-019A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111845 (US8623906, XW2-124B | US9174969, XW2-124B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111837 (US8623906, JHE-01-137 | US9174969, JHE-01-137) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111851 (US8623906, XW2-036 | US9174969, XW2-036) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111867 (US8623906, XW2-038F | US9174969, XW2-038F) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111863 (US8623906, JHE-02-017A | US9174969, JHE-02-017A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111860 (US8623906, JHE-01-155B | US9174969, JHE-01-155B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111858 (US8623906, JHE-02-010B | US9174969, JHE-02-010B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111878 (US8623906, JHE-02-019B | US9174969, JHE-02-019B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111831 (US8623906, JHE-02-068A | US9174969, JHE-02-068A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111836 (US8623906, JF020 | US9174969, JF020) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111850 (US8623906, JHE-02-012 | US9174969, JHE-02-012) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111830 (US8623906, XW2-038A | US8623906, XW3-002 | US91749...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111833 (US8623906, JF028 | US9174969, JF028) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111847 (US8623906, JHE-02-017B | US9174969, JHE-02-017B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111835 (US8623906, JF026 | US9174969, JF026) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111870 (US8623906, JHE-02-014 | US9174969, JHE-02-014) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111855 (US8623906, JF023 | US9174969, JF023) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111843 (US8623906, JF024 | US9174969, JF024) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111864 (US8623906, JHE-02-010C | US9174969, JHE-02-010C) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111862 (US8623906, JHE-02-033A | US9174969, JHE-02-033A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111842 (US8623906, JHE-02-063B | US9174969, JHE-02-063B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111856 (US8623906, JF039 | US9174969, JF039) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111852 (US8623906, JHE-02-035A | US9174969, JHE-02-035A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111823 (BDBM111857 | US8623906, JHE-02-001 | US8623906, JH...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111841 (US8623906, JF025 | US9174969, JF025) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111827 (US8623906, JHE-02-032A | US9174969, JHE-02-032A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111875 (US8623906, JHE-02-020A | US9174969, JHE-02-020A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111853 (US8623906, JF022 | US9174969, JF022) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111848 (US8623906, JF027 | US9174969, JF027) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111859 (US8623906, JF040 | US9174969, JF040) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111877 (US8623906, XW2-038E | US9174969, XW2-038E) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111849 (US8623906, XW2-119 | US9174969, XW2-119) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111869 (US8623906, JHE-02-010A | US9174969, JHE-02-010A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111881 (US8623906, JHE-01-169 | US9174969, JHE-01-169) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111840 (US8623906, JHE-02-032B | US9174969, JHE-02-032B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111861 (US8623906, JF021 | US9174969, JF021) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111872 (US8623906, XW2-031B | US9174969, XW2-031B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.13E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111868 (US8623906, JF033 | US9174969, JF033) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.17E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111866 (US8623906, JF035 | US9174969, JF035) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.22E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111846 (US8623906, JF038 | US9174969, JF038) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.26E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111871 (US8623906, JHE-02-029A | US9174969, JHE-02-029A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111874 (US8623906, XW2-124A | US9174969, XW2-124A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.32E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111879 (US8623906, JHE-02-015A | US9174969, JHE-02-015A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.43E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111830 (US8623906, XW2-038A | US8623906, XW3-002 | US91749...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.48E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111839 (US8623906, JHE-02-038 | US9174969, JHE-02-038) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.55E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111880 (US8623906, XW3-006 | US9174969, XW3-006) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111834 (US8623906, JHE-02-065A | US9174969, JHE-02-065A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.91E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111876 (US8623906, JHE-02-007 | US9174969, JHE-02-007) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.03E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111838 (US8623906, JHE-02-033B | US9174969, JHE-02-033B) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.07E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111882 (US8623906, JF031 | US9174969, JF031) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.28E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM53574 (4-[5-[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl-2,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 3.19E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111887 (US8623906, XW2-038D | US9174969, XW2-038D) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.46E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111821 (US8623906, XW2-038H | US9174969, JHE-02-023) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.73E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111888 (US8623906, JHE-02-052 | US9174969, JHE-02-052) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111883 (US8623906, JHE-02-117 | US9174969, JHE-02-117) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 7 (Homo sapiens (Human)) | BDBM53574 (4-[5-[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl-2,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 4.78E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111889 (US8623906, JHE-01-134A | US9174969, JHE-01-134A) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.03E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human)) | BDBM111890 (US8623906, XW2-038G | US9174969, XW2-038G) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.44E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF SOUTH FLORIDA US Patent | Assay Description IC50 values for indoline Shp2 inhibitors of the present invention, as determined by in vitro phosphotyrosine phosphatase activity (DiFMUP) assay. | US Patent US9174969 (2015) BindingDB Entry DOI: 10.7270/Q20R9N65 | |||||||||||
More data for this Ligand-Target Pair |